CN1440752A - 一种黄杨宁滴丸的处方及制备工艺 - Google Patents
一种黄杨宁滴丸的处方及制备工艺 Download PDFInfo
- Publication number
- CN1440752A CN1440752A CN 02104261 CN02104261A CN1440752A CN 1440752 A CN1440752 A CN 1440752A CN 02104261 CN02104261 CN 02104261 CN 02104261 A CN02104261 A CN 02104261A CN 1440752 A CN1440752 A CN 1440752A
- Authority
- CN
- China
- Prior art keywords
- polyethylene glycol
- cyclovirobuxinum
- drop pill
- temperature
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GMNAPBAUIVITMI-ABNIRSKTSA-N cyclovirobuxine d Chemical compound CC(C)([C@@H](NC)CC1)[C@H]2[C@@]31C[C@@]13CC[C@]3(C)[C@@H]([C@H](C)NC)[C@H](O)C[C@@]3(C)[C@@H]1CC2 GMNAPBAUIVITMI-ABNIRSKTSA-N 0.000 title claims abstract description 41
- 239000006187 pill Substances 0.000 title claims abstract description 31
- 238000000034 method Methods 0.000 title claims description 5
- IDOHCEDWHOEHNL-UHFFFAOYSA-N Cyclovirobuxin C Natural products C1C23CCC4(C)C(C(C)N(C)C)C(O)CC4(C)C3CCC3C21CCC(NC)C3(C)C IDOHCEDWHOEHNL-UHFFFAOYSA-N 0.000 title abstract description 8
- 229930187931 Cyclovirobuxine Natural products 0.000 title abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 239000007787 solid Substances 0.000 claims abstract description 7
- 239000008851 cyclovirobuxinum D Substances 0.000 claims description 33
- 239000002202 Polyethylene glycol Substances 0.000 claims description 19
- 229920001223 polyethylene glycol Polymers 0.000 claims description 19
- 229940079593 drug Drugs 0.000 claims description 13
- 239000012530 fluid Substances 0.000 claims description 9
- 229940093429 polyethylene glycol 6000 Drugs 0.000 claims description 7
- 239000002552 dosage form Substances 0.000 claims description 4
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 229940093430 polyethylene glycol 1500 Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000009413 insulation Methods 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 3
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 229920000151 polyglycol Polymers 0.000 abstract 1
- 239000010695 polyglycol Substances 0.000 abstract 1
- 241001656896 Buxus sinica Species 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012188 paraffin wax Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 241001656898 Buxus microphylla Species 0.000 description 3
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 229940057838 polyethylene glycol 4000 Drugs 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 229920002584 Polyethylene Glycol 6000 Polymers 0.000 description 1
- 241001448530 Rohdea japonica Species 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000003350 kerosene Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940074869 marquis Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- VBUNOIXRZNJNAD-UHFFFAOYSA-N ponazuril Chemical compound CC1=CC(N2C(N(C)C(=O)NC2=O)=O)=CC=C1OC1=CC=C(S(=O)(=O)C(F)(F)F)C=C1 VBUNOIXRZNJNAD-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
批号 | 000806 | 000808 | 000810 | 010930 | 011003 | 011005 | |
溶散时间(分钟) | 第1丸 | 6 | 7 | 6 | 6 | 6 | 6 |
第2丸 | 5 | 7 | 6 | 6 | 7 | 6 | |
第3丸 | 7 | 6 | 5 | 6 | 6 | 7 | |
第4丸 | 6 | 6 | 7 | 7 | 6 | 6 | |
第5丸 | 6 | 5 | 7 | 6 | 6 | 6 | |
第6丸 | 6 | 5 | 6 | 6 | 7 | 6 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02104261 CN1440752A (zh) | 2002-02-28 | 2002-02-28 | 一种黄杨宁滴丸的处方及制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02104261 CN1440752A (zh) | 2002-02-28 | 2002-02-28 | 一种黄杨宁滴丸的处方及制备工艺 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1440752A true CN1440752A (zh) | 2003-09-10 |
Family
ID=27768396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02104261 Pending CN1440752A (zh) | 2002-02-28 | 2002-02-28 | 一种黄杨宁滴丸的处方及制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1440752A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100391463C (zh) * | 2003-05-06 | 2008-06-04 | 天津天士力制药股份有限公司 | 一种黄杨宁滴丸及其制备工艺 |
CN100450489C (zh) * | 2003-12-11 | 2009-01-14 | 天津天士力制药股份有限公司 | 一种黄杨宁滴丸及其制备工艺 |
CN105476970A (zh) * | 2016-01-15 | 2016-04-13 | 因科瑞斯药业(营口)有限公司 | 一种黄杨宁分散片及其制备方法 |
-
2002
- 2002-02-28 CN CN 02104261 patent/CN1440752A/zh active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100391463C (zh) * | 2003-05-06 | 2008-06-04 | 天津天士力制药股份有限公司 | 一种黄杨宁滴丸及其制备工艺 |
CN100450489C (zh) * | 2003-12-11 | 2009-01-14 | 天津天士力制药股份有限公司 | 一种黄杨宁滴丸及其制备工艺 |
CN105476970A (zh) * | 2016-01-15 | 2016-04-13 | 因科瑞斯药业(营口)有限公司 | 一种黄杨宁分散片及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1440752A (zh) | 一种黄杨宁滴丸的处方及制备工艺 | |
CN112675255B (zh) | 用于预防治疗受试者抑郁症的药物组合物及用途 | |
CN100391463C (zh) | 一种黄杨宁滴丸及其制备工艺 | |
CN1872232B (zh) | 治疗脑血管疾病的药物组合物及其制备方法 | |
CN1872327B (zh) | 一种治疗腹泻的药物组合物 | |
CN101015573B (zh) | 败酱滴丸及其制备方法 | |
CN104547588A (zh) | 一种胃康灵滴丸的制备方法 | |
CN108567753A (zh) | 都梁滴丸及其制备工艺 | |
CN1330335C (zh) | 一种治疗妇科疾病的药物制备方法 | |
CN1872318B (zh) | 一种莪术油滴丸及其制备方法 | |
CN1366933A (zh) | 纳米七叶神安制剂药物及其制备方法 | |
CN1853713A (zh) | 安神补脑滴丸及其制备方法 | |
CN1626134A (zh) | 一种治疗慢性鼻炎、鼻窦炎的药物 | |
CN1539416A (zh) | 一种治疗急、慢性肝炎的药物及其制备工艺 | |
CN1362199A (zh) | 一种纳米祖师麻制剂药物及其制备方法 | |
CN1364482A (zh) | 纳米酸枣仁制剂药物及其制备方法 | |
CN100450489C (zh) | 一种黄杨宁滴丸及其制备工艺 | |
CN1515565A (zh) | 肿节风黄酮类香豆素类总提物及其药物组合物和用途 | |
CN104127407A (zh) | 一种水飞蓟素化合物及含有该提取物的药物组合物 | |
CN100421664C (zh) | 一种治疗惊厥、癫痫的药物 | |
CN1569048A (zh) | 清眩新的制备工艺及其制剂 | |
CN1362246A (zh) | 纳米小柴胡制剂药物及其制备方法 | |
CN111110689A (zh) | 一种活血化瘀通脉止痛的药物组合物及药物制剂 | |
CN1939369A (zh) | 人参茎叶皂苷滴丸及其制备方法 | |
CN1362106A (zh) | 纳米更年安制剂药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TASLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GAO HUA; CAO BAOCHENG Effective date: 20031208 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20031208 Applicant after: Tianjin Tianshili Pharmaceutical Co., Ltd. Applicant before: Gao Hua Applicant before: Cao Baocheng |
|
ASS | Succession or assignment of patent right |
Owner name: TIANJIN TASLY PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: GAO HUA; CAO BAOCHENG Effective date: 20031208 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20031208 Applicant after: Tianjin Tianshili Pharmaceutical Co., Ltd. Applicant before: Gao Hua Applicant before: Cao Baocheng |
|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |